Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct

Tilman Humpl, Syed H E Zaidi, James Y. Coe, Jennifer Russell, Yasufumi Kaneda, Hamid Massaeli, Lee N. Benson, Marlene Rabinovitch

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In congenital heart disease with left- or right-sided obstruction, prostaglandin E (PGE)1 or PGE2 is infused to maintain ductus arteriosus (DA) patency. We hypothesized that transfection of the DA with PGE synthase would lead to a greater production of PGE2 in situ and, hence, patency of the DA. The cDNA for human prostaglandin synthase was sequenced and ligated into a eukaryotic expression vector. The negative control was created by ligating the cDNA encoding the bacterial protein chloramphenicol acetyltransferase into the same plasmid. Transfection (600 μg DNA) was achieved in lambs within the first 24 h of life using the hemagglutinating virus of Japan (HVJ)-liposome transfection method with a custom-made, basket-weave-perforated catheter. Echocardiography was performed to assess DA patency until the time of sacrifice. To confirm expression of the transgene, PGE2 concentration was measured in organ culture of the DA by immunoassay and by Western immunoblotting of homogenized DA tissue. Patency of the DA was demonstrated by color Doppler in all the lambs (7/7) in which the PGE synthase was delivered, whereas functional closure was seen in the control group (6/6). The PGE2 concentration in the culture medium of the explanted DA in the treatment group was 3-fold higher than that of the control groups. Western immunoblotting confirmed the presence of PGE synthase in the treatment group. Gene transfer of PGE synthase to the DA is feasible and will maintain patency for at least 1 wk.

Original languageEnglish
Pages (from-to)976-980
Number of pages5
JournalPediatric Research
Volume58
Issue number5
DOIs
Publication statusPublished - 1 Nov 2005
Externally publishedYes

Fingerprint

Ductus Arteriosus
Prostaglandin-Endoperoxide Synthases
Patent Ductus Arteriosus
Dinoprostone
Transfection
Genes
Complementary DNA
Western Blotting
Sendai virus
Control Groups
Chloramphenicol O-Acetyltransferase
Bacterial Proteins
Organ Culture Techniques
Prostaglandins E
Transgenes
Immunoassay
Liposomes
Culture Media
Echocardiography
Heart Diseases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct. / Humpl, Tilman; Zaidi, Syed H E; Coe, James Y.; Russell, Jennifer; Kaneda, Yasufumi; Massaeli, Hamid; Benson, Lee N.; Rabinovitch, Marlene.

In: Pediatric Research, Vol. 58, No. 5, 01.11.2005, p. 976-980.

Research output: Contribution to journalArticle

Humpl, T, Zaidi, SHE, Coe, JY, Russell, J, Kaneda, Y, Massaeli, H, Benson, LN & Rabinovitch, M 2005, 'Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct', Pediatric Research, vol. 58, no. 5, pp. 976-980. https://doi.org/10.1203/01.PDR.0000182820.20333.2A
Humpl, Tilman ; Zaidi, Syed H E ; Coe, James Y. ; Russell, Jennifer ; Kaneda, Yasufumi ; Massaeli, Hamid ; Benson, Lee N. ; Rabinovitch, Marlene. / Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct. In: Pediatric Research. 2005 ; Vol. 58, No. 5. pp. 976-980.
@article{1a50d6cea63b4c63a7dc88f456030f84,
title = "Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct",
abstract = "In congenital heart disease with left- or right-sided obstruction, prostaglandin E (PGE)1 or PGE2 is infused to maintain ductus arteriosus (DA) patency. We hypothesized that transfection of the DA with PGE synthase would lead to a greater production of PGE2 in situ and, hence, patency of the DA. The cDNA for human prostaglandin synthase was sequenced and ligated into a eukaryotic expression vector. The negative control was created by ligating the cDNA encoding the bacterial protein chloramphenicol acetyltransferase into the same plasmid. Transfection (600 μg DNA) was achieved in lambs within the first 24 h of life using the hemagglutinating virus of Japan (HVJ)-liposome transfection method with a custom-made, basket-weave-perforated catheter. Echocardiography was performed to assess DA patency until the time of sacrifice. To confirm expression of the transgene, PGE2 concentration was measured in organ culture of the DA by immunoassay and by Western immunoblotting of homogenized DA tissue. Patency of the DA was demonstrated by color Doppler in all the lambs (7/7) in which the PGE synthase was delivered, whereas functional closure was seen in the control group (6/6). The PGE2 concentration in the culture medium of the explanted DA in the treatment group was 3-fold higher than that of the control groups. Western immunoblotting confirmed the presence of PGE synthase in the treatment group. Gene transfer of PGE synthase to the DA is feasible and will maintain patency for at least 1 wk.",
author = "Tilman Humpl and Zaidi, {Syed H E} and Coe, {James Y.} and Jennifer Russell and Yasufumi Kaneda and Hamid Massaeli and Benson, {Lee N.} and Marlene Rabinovitch",
year = "2005",
month = "11",
day = "1",
doi = "10.1203/01.PDR.0000182820.20333.2A",
language = "English",
volume = "58",
pages = "976--980",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct

AU - Humpl, Tilman

AU - Zaidi, Syed H E

AU - Coe, James Y.

AU - Russell, Jennifer

AU - Kaneda, Yasufumi

AU - Massaeli, Hamid

AU - Benson, Lee N.

AU - Rabinovitch, Marlene

PY - 2005/11/1

Y1 - 2005/11/1

N2 - In congenital heart disease with left- or right-sided obstruction, prostaglandin E (PGE)1 or PGE2 is infused to maintain ductus arteriosus (DA) patency. We hypothesized that transfection of the DA with PGE synthase would lead to a greater production of PGE2 in situ and, hence, patency of the DA. The cDNA for human prostaglandin synthase was sequenced and ligated into a eukaryotic expression vector. The negative control was created by ligating the cDNA encoding the bacterial protein chloramphenicol acetyltransferase into the same plasmid. Transfection (600 μg DNA) was achieved in lambs within the first 24 h of life using the hemagglutinating virus of Japan (HVJ)-liposome transfection method with a custom-made, basket-weave-perforated catheter. Echocardiography was performed to assess DA patency until the time of sacrifice. To confirm expression of the transgene, PGE2 concentration was measured in organ culture of the DA by immunoassay and by Western immunoblotting of homogenized DA tissue. Patency of the DA was demonstrated by color Doppler in all the lambs (7/7) in which the PGE synthase was delivered, whereas functional closure was seen in the control group (6/6). The PGE2 concentration in the culture medium of the explanted DA in the treatment group was 3-fold higher than that of the control groups. Western immunoblotting confirmed the presence of PGE synthase in the treatment group. Gene transfer of PGE synthase to the DA is feasible and will maintain patency for at least 1 wk.

AB - In congenital heart disease with left- or right-sided obstruction, prostaglandin E (PGE)1 or PGE2 is infused to maintain ductus arteriosus (DA) patency. We hypothesized that transfection of the DA with PGE synthase would lead to a greater production of PGE2 in situ and, hence, patency of the DA. The cDNA for human prostaglandin synthase was sequenced and ligated into a eukaryotic expression vector. The negative control was created by ligating the cDNA encoding the bacterial protein chloramphenicol acetyltransferase into the same plasmid. Transfection (600 μg DNA) was achieved in lambs within the first 24 h of life using the hemagglutinating virus of Japan (HVJ)-liposome transfection method with a custom-made, basket-weave-perforated catheter. Echocardiography was performed to assess DA patency until the time of sacrifice. To confirm expression of the transgene, PGE2 concentration was measured in organ culture of the DA by immunoassay and by Western immunoblotting of homogenized DA tissue. Patency of the DA was demonstrated by color Doppler in all the lambs (7/7) in which the PGE synthase was delivered, whereas functional closure was seen in the control group (6/6). The PGE2 concentration in the culture medium of the explanted DA in the treatment group was 3-fold higher than that of the control groups. Western immunoblotting confirmed the presence of PGE synthase in the treatment group. Gene transfer of PGE synthase to the DA is feasible and will maintain patency for at least 1 wk.

UR - http://www.scopus.com/inward/record.url?scp=27144440467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144440467&partnerID=8YFLogxK

U2 - 10.1203/01.PDR.0000182820.20333.2A

DO - 10.1203/01.PDR.0000182820.20333.2A

M3 - Article

C2 - 16183805

AN - SCOPUS:27144440467

VL - 58

SP - 976

EP - 980

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -